¼¼°èÀÇ ¹Ý·Áµ¿¹° ¹é½Å ½ÃÀåÀº 2025³â¿¡ 1Á¶ 4,260¾ï ´Þ·¯, 2030³â¿¡´Â 1Á¶ 9,250¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGRÀº 6.19%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.
¹Ý·Áµ¿¹° ¹é½Å ½ÃÀåÀº ¹Ý·Áµ¿¹° »çÀ°·üÀÇ »ó½Â, ¹Ý·Áµ¿¹°ÀÇ °Ç°¿¡ ´ëÇÑ ÀǽÄÀÇ ³ô¾ÆÁü, Àμö °øÅë °¨¿°ÁõÀÇ ¸¸¿¬ Áõ°¡ µîÀ» ¹è°æÀ¸·Î ²ÙÁØÈ÷ ¼ºÀåÇÒ ÀÚ¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° ¹é½ÅÀº µ¿¹°ÀÇ ¸é¿ª·ÂÀ» À¯ÁöÇÏ°í Æ¯È÷ ±¤°ßº´°ú °°Àº Áúº´À¸·ÎºÎÅÍ Áö¿ª °Ç°À» º¸È£ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ±â¼ú Áøº¸, Á¤ºÎ Áö¿øÃ¥, R&D ÅõÀÚ Áõ°¡´Â ½ÃÀå È®´ë¸¦ ´õ¿í °ÈÇϰí ÀÖ½À´Ï´Ù. °³ ¹é½Å ºÐ¾ß, ƯÈ÷ ÁÖ»ç ¹é½ÅÀº °¨¿°ÀÇ ¿¹¹æ¿¡ È¿°úÀûÀ̱⠶§¹®¿¡ »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
¹Ý·Áµ¿¹° »çÀ°·ü »ó½Â°ú Áúº´ ¸¸¿¬
ƯÈ÷ ¹Ð·¹´Ï¾ó ¼¼´ë¸¦ Áß½ÉÀ¸·Î ¹Ý·Áµ¿¹° »çÀ°ÀÇ ±ÞÁõÀº ÁÖÀÎÀÌ µ¿¹°ÀÇ °Ç°À» ¿ì¼±Çϱ⠶§¹®¿¡ ¹Ý·Áµ¿¹° ¹é½Å ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±¤°ßº´°ú °°Àº Àΰ£ Áü½Â °øÅë °¨¿°ÀÇ À¯ÇàÀº Á¤±âÀûÀÎ ¹é½Å Á¢Á¾ÀÇ Çʿ伺À» °Á¶ÇÕ´Ï´Ù. ±¤°ßº´Àº ÁÖ·Î °³¿¡ ÀÇÇØ °¨¿°µÇ¾î µ¿³²¾Æ½Ã¾Æ µî Áö¿ª¿¡¼ ³ôÀº ¹ß»ý·üÀ» º¸ÀÌ´Â µî, ¿©ÀüÈ÷ ¼¼°èÀÇ °Ç°»óÀÇ ½É°¢ÇÑ ¿ì·Á°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áúº´ ¿¹¹æ¿¡ ´ëÇÑ ¹é½ÅÀÇ È¿´ÉÀº ±¹¹ÎÀÇ ÀÇ½Ä Áõ°¡¿Í µ¿¹° ¾ÖÈ£ Ä·ÆäÀΰú ÇÔ²² ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
±â¼ú Áøº¸¿Í Á¤ºÎ Áö¿ø
¹é½Å °³¹ßÀÇ Çõ½ÅÀº È¿°ú¿Í ¾ÈÀü¼ºÀ» ³ôÀÌ°í ½ÃÀå µµÀÔÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. º¸Á¶±Ý°ú ÀÇ½Ä Çâ»ó ÇÁ·Î±×·¥À» Æ÷ÇÔÇÑ Á¤ºÎÀÇ Àû±ØÀûÀÎ ³ë·ÂÀº ƯÈ÷ Áúº´ ºÎ´ãÀÌ Å« Áö¿ª¿¡¼ ¹Ý·Áµ¿¹°ÀÇ ¹é½Å Á¢Á¾À» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ßºñ Áõ°¡´Â ÷´Ü ¹é½Å µµÀÔÀ» Áö¿øÇÏ°í »õ·Î¿î °Ç°°úÁ¦¸¦ ÇØ°áÇÏ¿© ½ÃÀå ÀáÀç·ÂÀ» È®´ëÇÕ´Ï´Ù. ÇÇÇÏ ¶Ç´Â ±ÙÀ° ³»¿¡ Åõ¿©µÇ´Â ÁÖ»ç ¹é½Å¿¡ ÁÖ¸ñÀÌ ¸ðÀÌ´Â °ÍÀ¸·Î, °ß°íÇÑ ¸é¿ª ¹ÝÀÀÀ» ÀÚ±ØÇÏ´Â ¹é½ÅÀÇ ¿ªÇÒÀÌ °Á¶µÇ¾î µ¿¹° ÀÇ·áÀÇ ¿äÁ¡ÀÌ µÇ°í ÀÖ½À´Ï´Ù.
°³ ¹é½Å ½ÃÀå È®´ë
°³ ¹é½Å ºÐ¾ß´Â ±¤°ßº´, °³ ÆÄº¸¹ÙÀÌ·¯½º, ·¾Å佺ÇǶóÁõ µîÀÇ ÀϹÝÀûÀÎ Áúº´°ú ½Î¿ï Çʿ伺À¸·Î ÀÎÇØ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °¨¿°¼º º´¿øÃ¼·ÎºÎÅÍ ¸öÀ» º¸È£Çϱâ À§ÇØ °í¾ÈµÈ ÁÖ»ç ¹é½ÅÀº ½Å·Ú¼ºÀÌ ³ô°í ¼öÀÇ»ç Àü¹®°¡ÀÇ Åõ¿©°¡ ¿ëÀÌÇϱ⠶§¹®¿¡ ³Î¸® »ç¿ëµË´Ï´Ù. ±¤°ßº´ ¹é½Å¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä, ƯÈ÷ Àú¡¤Á߼ҵ汹¿¡¼ ¼ö¿ä´Â À¯´Ï¼¼ÇÁ¿Í °°Àº ´Üü°¡ Àú·ÅÇÑ °ø±ÞÀ» º¸ÁõÇϰí ÀÖ´Â °æ¿ìµµ ÀÖ¾î, ÀÌ ºÐ¾ß¸¦ ´õ¿í °ÈÇϰí ÀÖ½À´Ï´Ù.
Áö¸®Àû Àü¸Á
¹Ì±¹Àº ¹Ý·Áµ¿¹° ¼ö°¡ ¸¹°í ƯÈ÷ ¹Ð·¹´Ï¾ó ¼¼´ëÀÇ °¡±¸¿¡¼ ¹Ý·Áµ¿¹° »çÀ°·üÀÌ ³ô±â ¶§¹®¿¡ ºÏ¹ÌÀÇ ¹Ý·Áµ¿¹° ¹é½Å ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ³ª¶ó´Â ¹Ý·Áµ¿¹°ÀÇ °Ç°¿¡ ÁßÁ¡À» µÎ°í ÀÖÀ¸¸ç, ÀÌ´Â Àΰ£ÀÇ °Ç° ÁõÁø°ú °°Àº ÀåÁ¡°ú °áÇÕÇÏ¿© ¹é½Å ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °³³ª °í¾çÀÌÀÇ »çÀ°¼ö°¡ ¸¹±â ¶§¹®¿¡ Á¤±âÀûÀÎ ¹é½Å Á¢Á¾ÀÌ ÇÊ¿äÇØ, °ßÁ¶ÇÑ ½ÃÀåÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. ij³ª´Ù¿Í °°Àº ´Ù¸¥ ºÏ¹Ì ±¹°¡µéµµ ¹Ý·Áµ¿¹°ÀÇ »çÀ°°ú ÀÇ½Ä Áõ°¡¸¦ ÅëÇØ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àεµ³ª Áß±¹°ú °°Àº ±¹°¡¿¡¼ ¹Ý·Áµ¿¹° »çÀ°À» ´Ã¸®°í Á¤ºÎÀÇ °Ç°¿¡ ´ëÇÑ ³ë·Â¿¡ ÈûÀÔ¾î ±Þ¼ÓÇÑ ¼ºÀåÀ» ±â´ëÇϰí ÀÖ½À´Ï´Ù.
¹Ý·Áµ¿¹° ¹é½Å ½ÃÀåÀº ¹Ý·Áµ¿¹° »çÀ° Áõ°¡, Àηù °øÅë °¨¿°ÀÇ À¯Çà, ¹é½Å ±â¼úÀÇ Áøº¸¿¡ ÃßÁøµÇ¾î ¾ÈÁ¤ÀûÀÎ ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù. °³ ¹é½Å, ƯÈ÷ ÁÖ»ç ¹é½ÅÀº Áúº´ ¿¹¹æ¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϱ⠶§¹®¿¡ ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ¿©ÀüÈ÷ ÁÖ¿ä ½ÃÀåÀÌÁö¸¸ ¾Æ½Ã¾ÆÅÂÆò¾çÀº °·ÂÇÑ ¼ºÀå °¡´É¼ºÀ» º¸¿©ÁÝ´Ï´Ù. Á¤ºÎÀÇ Áö¿ø°ú R&D ÅõÀÚ´Â ½ÃÀå Àü¸ÁÀ» ´õ¿í ³ôÀ̰í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ °Ç° ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó È¿°úÀûÀÎ ¹é½Å¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ½ÃÀåÀÇ Áö¼ÓÀûÀÎ È®´ë°¡ ¿¹»óµË´Ï´Ù.
¾î¶² ¿ëµµ·Î »ç¿ëµË´Ï±î?
¾÷°è ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¸®Àû È®´ë, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°ú ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ
The Global Pet Vaccine Market is expected to USD 1,426 billion in 2025 to USD 1,925 billion in 2030, at a CAGR of 6.19%.
The global pet vaccine market is poised for steady growth, driven by rising pet ownership, increasing awareness of pet health, and the growing prevalence of zoonotic diseases. Pet vaccines are essential for maintaining animal immunity and safeguarding community health, particularly against diseases like rabies. Technological advancements, supportive government initiatives, and increased R&D investments further propel market expansion. The canine vaccine segment, especially injectable vaccines, is expected to see substantial growth due to their effectiveness in preventing infectious diseases.
Market Growth Drivers
Rising Pet Ownership and Disease Prevalence
The surge in pet ownership, particularly among millennials, drives demand for pet vaccines as owners prioritize animal health. The increasing prevalence of zoonotic diseases, such as rabies, underscores the need for regular vaccinations. Rabies, transmitted primarily by dogs, remains a significant global health concern, with high incidence in regions like Southeast Asia. The effectiveness of vaccines in preventing such diseases, coupled with growing public awareness and animal welfare campaigns, fuels market growth.
Technological Advancements and Government Support
Innovations in vaccine development enhance efficacy and safety, boosting market adoption. Positive government initiatives, including subsidies and awareness programs, encourage pet vaccinations, particularly in regions with high disease burdens. Rising R&D expenditure supports the introduction of advanced vaccines, addressing emerging health challenges and expanding market potential. The focus on injectable vaccines, administered subcutaneously or intramuscularly, highlights their role in stimulating robust immune responses, making them a cornerstone of veterinary medicine.
Canine Vaccine Market Expansion
The canine vaccine segment is anticipated to grow significantly, driven by the need to combat common diseases like rabies, canine parvovirus, and leptospirosis. Injectable vaccines, designed to protect against infectious pathogens, are widely used due to their reliability and ease of administration by veterinary professionals. The global demand for rabies vaccines, particularly in low- and middle-income countries, further bolsters this segment, supported by organizations like UNICEF ensuring affordable supply.
Geographical Outlook
The United States dominates the North American pet vaccine market, driven by a large pet population and high pet ownership rates, particularly among millennial households. The country's focus on pet health, linked to benefits like improved human well-being, supports demand for vaccines. The substantial dog and cat population requires regular vaccinations, creating a robust market. Other North American countries, like Canada, also contribute through growing pet adoption and awareness. The Asia-Pacific region is expected to witness rapid growth, fueled by increasing pet ownership and government-backed health initiatives in countries like India and China.
The pet vaccine market is set for steady growth, propelled by rising pet ownership, zoonotic disease prevalence, and advancements in vaccine technology. The canine segment, particularly injectable vaccines, leads due to its critical role in disease prevention. The United States remains a key market, while Asia-Pacific shows strong growth potential. Government support and R&D investments further enhance market prospects. As pet health awareness grows, the demand for effective vaccines is expected to rise, ensuring sustained market expansion.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Pet Vaccine Market Segmentation: